Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.29
+0.54 (11.37%)
At close: Mar 28, 2025, 4:00 PM
5.44
+0.15 (2.84%)
After-hours: Mar 28, 2025, 7:59 PM EST
Serina Therapeutics Revenue
In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%. Serina Therapeutics had revenue of $-14.00K in the quarter ending December 31, 2024, a decrease of -100.45%.
Revenue (ttm)
$56.00K
Revenue Growth
-98.22%
P/S Ratio
938.24
Revenue / Employee
$5,091
Employees
11
Market Cap
52.54M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
Dec 31, 2023 | 3.15M | 2.56M | 433.05% |
Dec 31, 2022 | 591.50K | -2.87M | -82.93% |
Dec 31, 2021 | 3.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 6 days ago - Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 6 days ago - Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewsWire
- 7 weeks ago - Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire
- 2 months ago - Serina Therapeutics Announces Sale of UniverXome Subsidiary - GlobeNewsWire
- 2 months ago - Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors - GlobeNewsWire
- 3 months ago - Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024 - GlobeNewsWire
- 3 months ago - Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit - GlobeNewsWire